Found: 17
Select item for more details and to access through your institution.
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
- Published in:
- Emerging Infectious Diseases, 2021, v. 27, n. 1, p. 122, doi. 10.3201/eid2701.203772
- By:
- Publication type:
- Article
SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 5, p. 3047, doi. 10.1002/jmv.26840
- By:
- Publication type:
- Article
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH).
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 785, doi. 10.3390/vaccines12070785
- By:
- Publication type:
- Article
Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1348, doi. 10.3390/vaccines10081348
- By:
- Publication type:
- Article
Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060972
- By:
- Publication type:
- Article
Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1075, doi. 10.3390/vaccines9101075
- By:
- Publication type:
- Article
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.980698
- By:
- Publication type:
- Article
Frequency of SARS-CoV-2 Infections among Healthcare Workers in Germany: 3-Year Follow-Up Study.
- Published in:
- Infectious Disease Reports, 2024, v. 16, n. 4, p. 615, doi. 10.3390/idr16040047
- By:
- Publication type:
- Article
Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4606, doi. 10.3390/jcm10194606
- By:
- Publication type:
- Article
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1150667
- By:
- Publication type:
- Article
Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1143870
- By:
- Publication type:
- Article
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 4, p. 545, doi. 10.3390/v16040545
- By:
- Publication type:
- Article
Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 1, p. 119, doi. 10.3390/v15010119
- By:
- Publication type:
- Article
COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/v14040746
- By:
- Publication type:
- Article
Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 8, p. 1439, doi. 10.3390/diagnostics11081439
- By:
- Publication type:
- Article
GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.932043
- By:
- Publication type:
- Article
The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19).
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 01, doi. 10.3389/fgene.2022.960731
- By:
- Publication type:
- Article